导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.29% | 750/1050 |
| 近一周 | -4.27% | 1011/1104 |
| 近一月 | -2.02% | 227/1102 |
| 近一季 | -5.45% | 439/1092 |
| 近半年 | -17.83% | 951/1070 |
| 近一年 | 20.15% | 235/1018 |
| 近两年 | 83.31% | 267/926 |
| 近三年 | 68.52% | 157/834 |
| 成立以来 | 356.31% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.43% 303/1070 |
-15.89% 1034/1101 |
- - |
- - |
| 2025 | 85.80% 29/1065 |
7.27% 267/1014 |
4.77% 313/1038 |
40.27% 189/1050 |
17.87% 13/1065 |
| 2024 | 2.29% 518/1011 |
12.82% 12/960 |
1.56% 212/983 |
4.43% 899/991 |
-14.51% 979/1011 |
| 2023 | -0.89% 114/952 |
5.95% 257/880 |
-6.90% 639/895 |
2.99% 20/915 |
-2.46% 265/952 |
| 2022 | -12.30% 124/867 |
2.21% 3/773 |
2.17% 661/806 |
-8.39% 160/845 |
-8.32% 745/867 |
| 2021 | 22.06% 146/740 |
0.37% 138/580 |
10.11% 355/659 |
17.13% 25/704 |
-5.71% 609/740 |
| 2020 | 87.31% 70/554 |
-7.98% 356/419 |
16.18% 334/466 |
29.68% 9/517 |
35.11% 25/554 |
| 2019 | 34.24% 263/410 |
13.17% 1028/1146 |
0.09% 326/1228 |
1.23% 299/390 |
17.07% 31/410 |
| 2018 | -34.72% 267/349 |
- - |
-9.35% 453/990 |
-5.10% 465/1000 |
-16.51% 941/1080 |
| 2017 | 25.21% 62/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 创金合信资源股票发起式C VS. 东吴新产业精选股票A(580008) |